v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Class A
Common Class B
Common Stock
Common Stock
Common Class A
Common Stock
Common Class B
Additional Paid-in Capital
Retained Earnings (Accumulated Deficit)
Accumulated Other Comprehensive Income (Loss)
Beginning Balance at Dec. 31, 2018 $ 1,334,260       $ 1,372 $ 40 $ 1,693,512 $ (360,664) $ 0
Beginning Balance (in shares) at Dec. 31, 2018         137,180,213 4,045,199      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) 3,125             3,125  
Compensation expense related to granting of stock awards 3,573       $ 14   3,559    
Compensation expense related to granting of stock awards (in shares)         1,406,722        
Issuance of common stock related to the Employee Stock Purchase Plan ("ESPP") 379       $ 1   378    
Issuance of common stock related to the Employee Stock Purchase Plan (ESPP) (in shares)         84,958        
Exercise of stock options 244       $ 2   242    
Exercise of stock options (in shares)         180,300        
Purchase of vested employee restricted stock units (1,426)       $ (2)   (1,424)    
Purchase of vested employee restricted stock units (in shares)         (204,499)        
Payment of dividends on common stock (12,913)           (12,913)    
Dividend equivalents, net of forfeitures (463)           (463)    
Ending Balance at Mar. 31, 2019 1,331,498       $ 1,387 $ 40 1,682,891 (352,820) 0
Ending Balance (in shares) at Mar. 31, 2019         138,647,694 4,045,199      
Beginning Balance at Dec. 31, 2018 1,334,260       $ 1,372 $ 40 1,693,512 (360,664) 0
Beginning Balance (in shares) at Dec. 31, 2018         137,180,213 4,045,199      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) 67,323                
Net unrealized gain (loss) on derivatives (577)                
Ending Balance at Sep. 30, 2019 1,367,870 $ 1,337 $ 40       1,655,690 (288,620) (577)
Ending Balance (in shares) at Sep. 30, 2019   133,583,672 4,045,199            
Beginning Balance at Mar. 31, 2019 1,331,498       $ 1,387 $ 40 1,682,891 (352,820) 0
Beginning Balance (in shares) at Mar. 31, 2019         138,647,694 4,045,199      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) 25,992             25,992  
Compensation expense related to granting of stock awards 3,393           3,393    
Compensation expense related to granting of stock awards (in shares)         (38,774)        
Issuance of common stock related to the Employee Stock Purchase Plan ("ESPP") 364       $ 1   363    
Issuance of common stock related to the Employee Stock Purchase Plan (ESPP) (in shares)         73,791        
Purchase of vested employee restricted stock units (1,300)       $ (2)   (1,298)    
Purchase of vested employee restricted stock units (in shares)         (216,828)        
Payment of dividends on common stock (13,140)           (13,140)    
Dividend equivalents, net of forfeitures 1,059           1,059    
Net unrealized gain (loss) on derivatives (224)               (224)
Ending Balance at Jun. 30, 2019 1,347,642       $ 1,386 $ 40 1,673,268 (326,828) (224)
Ending Balance (in shares) at Jun. 30, 2019         138,465,883 4,045,199      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) 38,208             38,208  
Compensation expense related to granting of stock awards 3,165 $ 0         3,165    
Compensation expense related to granting of stock awards (in shares)   18,232              
Issuance of common stock related to the Employee Stock Purchase Plan ("ESPP") 288 $ 1         287    
Issuance of common stock related to the Employee Stock Purchase Plan (ESPP) (in shares)   100,965              
Common stock repurchase (18,340)     $ (50)     (18,290)    
Common stock repurchase (in shares)   (5,000,000)              
Purchase of vested employee restricted stock units (4)           (4)    
Purchase of vested employee restricted stock units (in shares)   (1,408)              
Payment of dividends on common stock (2,684)           (2,684) 0  
Dividend equivalents, net of forfeitures (52)           (52) 0  
Net unrealized gain (loss) on derivatives (353)               (353)
Ending Balance at Sep. 30, 2019 1,367,870 $ 1,337 $ 40       1,655,690 (288,620) (577)
Ending Balance (in shares) at Sep. 30, 2019   133,583,672 4,045,199            
Beginning Balance at Dec. 31, 2019 881,443       $ 1,339 $ 40 1,655,781 (775,578) (139)
Beginning Balance (in shares) at Dec. 31, 2019         133,867,621 4,045,199      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) (9,138)             (9,138)  
Compensation expense related to granting of stock awards 4,117       $ 4   4,113    
Compensation expense related to granting of stock awards (in shares)         440,129        
Issuance of common stock related to the Employee Stock Purchase Plan ("ESPP") 241       $ 2   239    
Issuance of common stock related to the Employee Stock Purchase Plan (ESPP) (in shares)         165,756        
Purchase of vested employee restricted stock units (1,394)       $ (4)   (1,390)    
Purchase of vested employee restricted stock units (in shares)         (432,472)        
Payment of dividends on common stock (3,221)           (3,221)    
Dividend equivalents, net of forfeitures 493           493    
Net unrealized gain (loss) on derivatives (2,354)               (2,354)
Ending Balance at Mar. 31, 2020 870,187       $ 1,341 $ 40 1,656,015 (784,716) (2,493)
Ending Balance (in shares) at Mar. 31, 2020         134,041,034 4,045,199      
Beginning Balance at Dec. 31, 2019 881,443       $ 1,339 $ 40 1,655,781 (775,578) (139)
Beginning Balance (in shares) at Dec. 31, 2019         133,867,621 4,045,199      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) $ (79,827)                
Compensation expense related to granting of stock awards (in shares) 66,000                
Net unrealized gain (loss) on derivatives $ (2,099)                
Ending Balance at Sep. 30, 2020 803,687 $ 1,340 $ 40       1,659,950 (855,405) (2,238)
Ending Balance (in shares) at Sep. 30, 2020   133,949,367 4,045,199            
Beginning Balance at Mar. 31, 2020 870,187       $ 1,341 $ 40 1,656,015 (784,716) (2,493)
Beginning Balance (in shares) at Mar. 31, 2020         134,041,034 4,045,199      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) (53,811)             (53,811)  
Compensation expense related to granting of stock awards 2,274           2,274    
Compensation expense related to granting of stock awards (in shares)         (30,040)        
Purchase of vested employee restricted stock units (53)       $ (1)   (52)    
Purchase of vested employee restricted stock units (in shares)         (41,002)        
Payment of dividends on common stock (189)           (189)    
Dividend equivalents, net of forfeitures 162           162    
Net unrealized gain (loss) on derivatives (260)               (260)
Ending Balance at Jun. 30, 2020 818,310       $ 1,340 $ 40 1,658,210 (838,527) (2,753)
Ending Balance (in shares) at Jun. 30, 2020         133,969,992 4,045,199      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) (16,878)             (16,878)  
Compensation expense related to granting of stock awards 1,784 $ 0         1,784    
Compensation expense related to granting of stock awards (in shares)   (20,625)              
Dividend equivalents, net of forfeitures (44)           (44)    
Net unrealized gain (loss) on derivatives 515               515
Ending Balance at Sep. 30, 2020 $ 803,687 $ 1,340 $ 40       $ 1,659,950 $ (855,405) $ (2,238)
Ending Balance (in shares) at Sep. 30, 2020   133,949,367 4,045,199